Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.940
-0.080-0.61%
Volume:2.11M
Turnover:27.33M
Market Cap:22.80B
PE:-47.93
High:13.150
Open:12.980
Low:12.860
Close:13.020
52wk High:20.620
52wk Low:5.130
Shares:1.76B
HK Float Shares:1.49B
Volume Ratio:0.36
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.270
ROE:-3.55%
ROA:-2.10%
PB:3.05
PE(LYR):-47.93
PS:14.27

Loading ...

An Intrinsic Calculation For InnoCare Pharma Limited (HKG:9969) Suggests It's 45% Undervalued

Simply Wall St.
·
Jan 06

INNOCARE (09969) Grants 1.4 Million Restricted Share Units

Stock News
·
Dec 31, 2025

Guoyuan International Sets INNOCARE (09969) Target Price at HK$16.81 with "Buy" Rating

Stock News
·
Dec 24, 2025

Is InnoCare Pharma (SEHK:9969) Quietly Recasting Its Future Around Autoimmune Dermatology?

Simply Wall St.
·
Dec 21, 2025

HK Stock Movement | INNOCARE (09969) Rises Over 4% as Self-Developed Novel TYK2 Inhibitor ICP-332 Gains Approval for Phase II/III Clinical Trials in CSU Treatment

Stock News
·
Dec 19, 2025

InnoCare Pharma Receives Regulatory Approval to Begin Clinical Trial of Drug in Systemic Lupus

MT Newswires Live
·
Dec 15, 2025

InnoCare Pharma (SEHK:9969): Assessing Valuation After Landmark NTRK Solid-Tumor Approval for Zurletrectinib

Simply Wall St.
·
Dec 15, 2025

Innocare Pharma Limited (688428.SH): Orelabrutinib Meets Primary Endpoint in Phase IIb Study for Systemic Lupus Erythematosus

Stock News
·
Dec 14, 2025

First Solid-Tumor Drug Approval Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Dec 13, 2025

HK Stock Movement | INNOCARE (09969) Rises Over 3% as NDA Submission for Zorletinib in Pediatric Patients Expected Soon

Stock News
·
Dec 12, 2025

Everest Medicines (01952) Announces Strategic Collaboration with Haisco; Silver Prices Hit Record High

Stock News
·
Dec 12, 2025

InnoCare Pharma Gets China Nod for Tumor Drug

MT Newswires Live
·
Dec 11, 2025

InnoCare Pharma (09969) Releases Monthly Return for 30 November 2025, No Changes in Share Capital

Bulletin Express
·
Dec 04, 2025

InnoCare Pharma (SEHK:9969) Valuation in Focus After Revenue Growth and Narrowed Losses

Simply Wall St.
·
Nov 27, 2025

Earnings Update: InnoCare Pharma Limited (HKG:9969) Just Reported Its Interim Results And Analysts Are Updating Their Forecasts

Simply Wall St.
·
Nov 16, 2025

InnoCare Pharma (SEHK:9969): Evaluating Valuation After Sales Growth and Pipeline Advances Spark Market Interest

Simply Wall St.
·
Nov 14, 2025

InnoCare Pharma Logs Over 34 Million Yuan in Q3 Loss

MT Newswires Live
·
Nov 13, 2025

InnoCare Pharma Limited (9969) Releases 2025 Third Quarter Results and Updates Nomination Committee

Bulletin Express
·
Nov 13, 2025

Innocare Pharma Limited (688428.SH) Reports Q3 Results with Net Loss of 64.41 Million Yuan

Stock News
·
Nov 13, 2025

InnoCare Pharma Limited (09969) Announces Monthly Securities Movements for October 2025

Bulletin Express
·
Nov 05, 2025